Top compounds associated with response to LYPLA2

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	GDC-0879	CTRPv2	pan-cancer	AAC	0.092	0.009
mRNA	selumetinib:tretinoin (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.092	0.009
mRNA	Dasatinib	CTRPv2	pan-cancer	AAC	-0.094	0.009
mRNA	Irinotecan	gCSI	pan-cancer	AAC	-0.15	0.009
mRNA	selumetinib:GDC-0941 (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.093	0.01
mRNA	selumetinib:decitabine (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.087	0.01
mRNA	navitoclax:sorafenib (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.09	0.01
mRNA	selumetinib:MK-2206 (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.09	0.01
mRNA	CCT036477	CTRPv2	pan-cancer	AAC	-0.085	0.01
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.088	0.01

Download CSV